Maybe your labs shifted a bit. Maybe you heard Descovy is “easier on the kidneys.” Maybe your insurance plan changed. Whatever the reason, if you’re thinking about switching from Truvada to Descovy for PrEP, you’re in the right place.

Both are great options for preventing HIV when taken daily. And neither one is objectively “better” than the other. It’s more about which one is the best fit for you right now. That means looking at your labs, how you tolerate medication, and what your insurance will cover — and this guide will walk you through it all step-by-step. 

We’ll talk about the differences between Truvada and Descovy, what the research shows, who might benefit from switching, common side effects, and how to make the switch safely (if that’s the right choice for you). 

Truvada vs Descovy: what’s the difference?

When comparing Truvada and Descovy, it helps to start with what they have in common.

Truvada was the first PrEP medication approved by the FDA in 2012. It has a long track record, and many people still use it today. Descovy is newer, approved for HIV treatment in 2016 and for PrEP in 2019.

Both are daily oral PrEP medications designed to prevent HIV by stopping the virus from replicating in the body. Neither cures HIV, but when taken consistently, both are over 99% effective at preventing infection.

They work in similar ways, too. Each combines emtricitabine with a form of tenofovir to block an enzyme HIV needs to reproduce, helping stop the virus from establishing infection in the first place.

The main difference comes down to the type of tenofovir:

  • Truvada uses tenofovir disoproxil fumarate (TDF)
  • Descovy uses tenofovir alafenamide (TAF)

Both forms work once they’re inside your cells, but they get there a bit differently. With TDF, more of the medication travels through the bloodstream first. TAF sends more of it directly into cells, which is why Descovy has shown fewer kidney- and bone-related changes in some studies.

Another difference is who each medication is approved for.*Descovy isn’t approved for these groups because it wasn’t studied in those populations during clinical trials, not because of a known safety concern.

Who might consider switching?

Switching from Truvada to Descovy isn’t something everyone needs to do. Many stay on Truvada for years without any meaningful side effects or health concerns.

When switching does come up, it’s usually because something has shifted in your health, your experience on PrEP, or your coverage. Some common situations where a switch might be worth discussing include:

  • If your kidney labs have started to shift: Tenofovir is processed by the kidneys, and over time, some folks see small changes in kidney function. Because Descovy leads to lower levels of tenofovir in the bloodstream, a provider may raise it as an option if your labs start trending in a direction they want to watch more closely.
  • If bone health is on your radar: Truvada has been linked to small decreases in bone mineral density in some cases. These changes are often modest and reversible, but they matter more with osteoporosis risk factors or existing bone concerns. Descovy has shown less impact on bone density, which is why it may come up in conversations about longer-term use.
  • If side effects never fully settled: Most PrEP side effects are mild and temporary, especially during the first few weeks. If symptoms persist or interfere with daily life, it’s worth discussing whether switching medications could help.
  • If insurance or access has changed: Insurance plans change, formularies shift, and assistance programs come and go. Sometimes Descovy becomes the easier or more affordable option. Other times, generic Truvada remains the best fit.

In most cases, switching isn’t urgent. It’s often just a check-in to see how things are going and whether your current PrEP still feels like a good fit. 

Not sure if Descovy is right for you? Book a virtual consult with Freddie.

When staying on Truvada may be the better choice

There are also times when staying on Truvada is the option that fits best. That may be the case when:

  • Your labs have been stable, and you feel good on it.
  • Side effects haven’t been an issue.
  • Generic Truvada is the more affordable option.
  • Your HIV risk includes vaginal sex or injection drug use, where Descovy isn’t approved.

If your current plan is working well, it’s okay to stay with it. PrEP works best when it feels manageable and fits into your life.

What the research really says

When you look at the research, the takeaway is pretty reassuring: both Truvada and Descovy work very well for HIV prevention when taken daily. And neither one has a clear advantage over the other for preventing HIV, which is why both remain recommended PrEP options.

The biggest head-to-head study comparing them followed people for about two years and found nearly identical protection. In other words, both did their job when people took them consistently.

Where some differences show up are around kidney health, bone density, and cholesterol levels. One study found that TAF (the form used in Descovy) tends to show smaller changes in kidney function and bone density on lab tests than the form in Truvada (TDF). 

This also doesn’t make Truvada unsafe or hard on your body. Many people use it for years and feel good on it. When changes do happen, they’re usually small and show up in labs first, not in how you feel day to day.

Because of that, routine PrEP check-ins are just part of keeping an eye on your health and making sure your medication continues to fit your needs over time.

How clinicians think about switching from Truvada to Descovy

Clinicians don’t make switching decisions based on a single study or lab result. So, one slightly elevated number usually isn’t enough to trigger a change. Instead, they step back and look at the bigger picture, like:

  • Kidney function, bone health, and other risk factors: Labs are reviewed over time to spot trends, not one-off blips. In plain terms, it’s about patterns, not one number.
  • Age and medical history: Someone in their early twenties with no other health concerns may tolerate Truvada without issue for years. Someone older or on other medications that affect kidney function might benefit from a different approach earlier.
  • Duration of treatment: Providers also factor in how long someone plans to stay on PrEP. For short-term use, the difference between medications may not matter much. For long-term prevention, even small differences in side effect profiles can add up.

At Freddie, the care team takes the same approach. They look at your labs, your health history, and your plans before suggesting any change, with the focus on finding a PrEP option that stays effective and well-tolerated for you over time.

Side effects and safety by drug type

Because Truvada and Descovy use similar ingredients, many of their side effects overlap. Most are mild, and if they show up, they usually happen early and settle within a few weeks.

Mild side effects

Common with both Truvada and Descovy:

  • Nausea or an upset stomach that often improves as your body adjusts.
  • Diarrhea that is usually mild and short-lived.
  • Headaches that tend to fade after the first few weeks.
  • Fatigue while your body gets used to the medication.
  • Rash that should be checked if it feels unusual or persistent.

Reported more often with Truvada:

  • Vivid or unusual dreams that some notice at the start.
  • Dizziness, especially in the early weeks.
  • Trouble sleeping or lighter sleep than usual.
  • Skin darkening (hyperpigmentation) — uncommon but possible.

Serious side effects

Serious side effects are uncommon with both medications, but regular monitoring helps keep things on track.

  • Kidney changes that providers watch through routine labs.
  • Small bone density shifts are seen more often with Truvada.
  • Liver concerns, especially for those with existing liver conditions.
  • Lactic acidosis, which is very rare.
  • Hepatitis B flare-ups if PrEP is stopped without guidance.
  • Immune reconstitution syndrome (mainly relevant in HIV treatment).

These risks are also why regular check-ins are built into PrEP care, giving you and your provider time to look at labs and keep everything on track.

*Only applicable if HIV-positive

Have questions? Freddie’s clinicians can walk you through side effects, lab results, and switching options.

Cost, coverage, and access (2026)

Cost is one of the biggest reasons people pause and rethink their PrEP options. It’s also one of the most confusing parts of the conversation because the number listed on a price sheet usually isn’t what people actually pay.

Here’s how the costs of Truvada and Descovy compare in real life:

  • Truvada: Brand-name Truvada has a high list price in the U.S. (around $2,000 per month), but most people don’t pay that amount. Insurance coverage, federal and state PrEP programs, and manufacturer assistance can significantly reduce costs. Generic versions (tenofovir disoproxil fumarate/emtricitabine) are widely available and much more affordable, which is why Truvada remains a practical option when cost is a priority.
  • Descovy: Descovy has a similar list price on paper, but again, that’s rarely the final number. Many private insurance plans cover Descovy for PrEP, and copay assistance programs can bring costs down substantially. With the right coverage, many people pay little or nothing. 

Coverage options

Coverage and support programs matter more than list prices. In the U.S., PrEP is classified as essential preventive care. Under current preventive care requirements, most private insurance plans are required to cover PrEP medications — including Truvada and Descovy — without cost-sharing.

That often looks like:

  • No copay for the medication.
  • No deductible before coverage kicks in.
  • Coverage for routine labs and provider visits related to PrEP.

Military health plans, including TRICARE, also cover HIV PrEP medications for eligible beneficiaries.

Of course, insurance isn’t always perfectly smooth. Some plans require prior authorizations or have pharmacy rules that slow things down. When that happens, copay assistance programs can help bridge the gap. For Descovy, these programs can cover thousands of dollars per year in copays, and in many cases bring the cost down to zero.

In Canada? PrEP coverage depends on where you live. Some provinces cover it fully through public programs, while others offer partial coverage through provincial drug plans.

If public coverage doesn’t cover the full cost (or you don’t qualify), private insurance can help with the remainder, and assistance programs may lower costs further.

Access still matters

Even when cost and coverage are sorted out, access can still shape how easy PrEP feels to stay on. Not everyone has a family doctor they feel comfortable talking to about PrEP. Some live far from clinics, and others juggle work, childcare, or schedules that make appointments tough. For many LGBTQ+ folks, finding a provider who feels knowledgeable and affirming can also take extra effort.

That’s why flexible care options can make a real difference. Being able to connect with a clinician from home, review labs online, and manage prescriptions without lots of in-person visits can take a lot of pressure off. Lab work can often be done locally or with at-home options too, which helps PrEP fit more easily into everyday life.

Freddie was built around these access challenges. Care is provided online by clinicians who specialize in PrEP and HIV prevention, so you can get help with labs, prescriptions, insurance questions, and follow-up care in one place — without leaving your home.

How to switch safely: lab work, provider review & timeline

Switching from Truvada to Descovy isn’t a decision you should make alone. It’s something that needs to be done with a provider to ensure your HIV-negative status is confirmed before the transition. The process is usually simple and follows a few clear steps that your provider will walk you through: 

Step 1: Lab work comes first: Your provider will make sure your HIV test is current and review recent labs, especially kidney function. If labs aren’t up to date, you may be asked to complete them before switching.

Step 2: Provider review: This is a quick check-in on your health history, current medications, and how PrEP has been going so far. The goal is to confirm Descovy makes sense for you.

Step 3: Timing the switch: Most people switch directly from one medication to the other. That usually means finishing one and starting the other the next day, with no tapering period.

Step 4: Stick to one medication: Truvada and Descovy shouldn’t be mixed or alternated. You take one or the other, exactly as prescribed.

After a switch, follow-up labs help confirm everything remains stable. For most people, the process is smooth and uneventful. It’s really just about having the right checks in place so your protection stays consistent.

Frequently Asked Questions

Is it okay to switch from Truvada to Descovy?

Yes, when it’s done with a provider. Many switches happen because of lab trends, side effects that didn’t fully settle, or coverage changes. Both medications are highly effective when taken daily. The key is planning the transition so there’s no gap in protection and you feel clear on why you’re switching. 

Is Descovy really better than Truvada?

Not universally. Descovy can be a good option for those with kidney or bone considerations, but Truvada works just as well for preventing HIV and remains a first-line choice. For many, both are great options. The “better” one depends on your health, your labs, and what feels sustainable.

Do you gain weight on Descovy vs Truvada?

Some studies have found small differences in average weight changes between the two medications. In the DISCOVER clinical trial, people taking Descovy had slightly larger average weight increases compared to those taking Truvada (about +1.7 kg vs +0.5 kg over 96 weeks). This doesn’t mean everyone will gain weight, and researchers believe the difference may be partly because Truvada can have a mild weight-suppressing effect. For most people, weight changes are small and influenced more by lifestyle, health, and natural body changes than by the medication itself.

What is the success rate of Descovy?

Descovy is very effective when taken daily. In a 2-year study, 99.7% of people taking Descovy for PrEP stayed HIV-negative. Truvada showed almost the same result at 99.4%. Like all PrEP, the biggest factor is taking it consistently.

Still not sure? We can help

Deciding whether to switch can feel like a lot when labs, cost, and coverage are all in the mix. You don’t have to sort it out alone.

Freddie clinicians can review your labs, talk through side effects, and help you understand your coverage options. If a switch makes sense, they’ll guide you through it. If it doesn’t, you’ll know that too.

A quick consult can give you the clarity you need to feel confident about your next step.